Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine. (Q34014627)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

0 references

secondary progressive multiple sclerosis

0 references

multiple sclerosis

0 references

Kenneth J Smith

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

T Hayton

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

J Furby

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

D R Altmann

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

R Brenner

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

J Chataway

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

K Hunter

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

D J Tozer

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

D H Miller

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

R Kapoor

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

9 September 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Journal of Neurology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

259

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

505-514

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21904901%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

https://scigraph.springernature.com/pub.10.1007/s00415-011-6212-9

0 references

Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup?

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Sodium-mediated axonal degeneration in inflammatory demyelinating disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Unified segmentation

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Analysis of MTR histograms in multiple sclerosis using principal components and multiple discriminant analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Enhancing adherence in clinical research

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Imaging correlates of axonal swelling in chronic multiple sclerosis brains.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Magnetization transfer imaging to monitor the evolution of MS: A 1-year follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6212-9

21 January 2018

Axonal protection achieved in a model of multiple sclerosis using lamotrigine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scan-rescan variation of measures derived from brain magnetization transfer ratio histograms obtained in healthy volunteers by use of a semi-interleaved magnetization transfer sequence.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrically active axons degenerate when exposed to nitric oxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34014627&oldid=1410651743"